Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome.

Dolled-Filhart M, McCabe A, Giltnane J, Cregger M, Camp RL, Rimm DL
Cancer Res. 2006 66 (10): 5487-94

PMID: 16707478 · DOI:10.1158/0008-5472.CAN-06-0100

MeSH Terms (12)

Algorithms beta Catenin Biomarkers, Tumor Breast Neoplasms Cell Line, Tumor Data Interpretation, Statistical Enzyme-Linked Immunosorbent Assay Female Humans Microarray Analysis Middle Aged Prognosis

Connections (1)

This publication is referenced by other Labnodes entities: